title: The FDA reevaluates alternative site testing for blood glucose.
authors.affiliation: Robert Wood Johnson College of Medicine, University of Medicine and Dentistry of New Jersey, New Brunswick, New Jersey, USA. barry_ginsberg@bd.com
authors.forename: Barry H
authors.initials: BH
authors.lastname: Ginsberg
mesh_terms: D001132:Arm / Q000098:blood supply; D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation / Q000379:methods / Q000592:standards*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood*; D005385:Fingers / Q000098:blood supply; D006801:Humans; D011786:Quality Control; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D001786:Blood Glucose